site:www.pharmexec.com - Search Videos

Future Partnership Plans for GT-02287 and the Magellan Platform in Parkinson’s Research

Future Partnership Plans for GT-02287 and the Magellan Platform i…

What's Causing So Many Phase III Trials to Head for Avoidable Failure?

What's Causing So Many Phase III Trials to Head for Avoidable Failure?

The Challenges and Advantages of US Healthcare in a Worldwide Perspective

The Challenges and Advantages of US Healthcare in a Worldwide Per…

Asembia 2025: Why AI Could Be the Key to Solving Access Challenges in Healthcare

Asembia 2025: Why AI Could Be the Key to Solving Access Challenge…

Early Trial Success Signals Promise for GT-02287 in Parkinson’s Disease Treatment

Early Trial Success Signals Promise for GT-02287 in Parkinson’s Disea…

How Pharmaceutical Companies Can Mitigate a Potential Drop in Demand Due to Tariffs

How Pharmaceutical Companies Can Mitigate a Potential Drop in D…

What is the Timeline for True AI Implementation for Digital Twins?

What is the Timeline for True AI Implementation for Digital Twins?

AD04 Study Highlights Consistent Bioavailability and Safety for Alco…

AbbVie Positions Temab-A ADC for Tumor-Agnostic Use in Multiple C…

Amgen Aims to Cut US Cardiovascular Events by 50% by …

Real-World Data Shows Poor LDL Control Despite Available Treatment

Getting JUV-161 to Phase I in 2025

Regeneron’s DB-OTO: Overcoming Clinical and Manufacturing Hurdle…

Emrelis Could Establish AbbVie as a Competitor in MET-High NSCLC Tr…

What the Emrelis Approval Means for Pharma and Biotech ADC Strat…

How Emrelis Is Expanding Treatment Options for Solid Tumo…

IMU-856 Shows Promise in Celiac Disease: Histologic Protection an…

GAIN Therapeutics Ramps Up for Next Big Step in Parkinson’s Dru…

IMU-856: A Potential Solution for Celiac Patients Facing Cross-Cont…

Exploring the Promise of E7386 and Lenvatinib Combination Therapy i…

Asembia 2025: Digital Health and Biosimilars Shape the Future of P…

Asembia 2025: How AI and Payer Collaboration Are Shaping Pharm…

New Insights Into T Cell Exhaustion and Inflammation in Long COVID

Asembia 2025: How Specialty Pharmacies Are Evolving to Supp…

Lynparza and Breast Cancer: Study Finds Reduced Recurrence Risk i…

Monitoring the Safety of WHISTLE-PF in IPF Across Diverse Populati…

AI Drug Discovery Impact on Pharmaceutical Value Chain

Executive Orders and Drug Pricing: Constitutional Limits on the Most …

Eisai Highlights Long-Term Efficacy of Lenvima in Advanced HCC Trea…

Combatting Hallucinations in FDA’s AI

See more videos